strides pharma share price: Smallcap pharma stock jumps over 11% as arm receives tentative USFDA approval for HIV drug Dolutegravir
The company has 260 cumulative ANDA filings (including the recently acquired portfolio from Endo at Chestnut Ridge) with the USFDA, of which 230+ ANDAs have been approved. The company is eyeing around 60 new product launches over the next three years in the US.
Source: indiatimes.com